Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Parasites use Trojan horse tactic
Parasitic worm
The research could lead to new strategies for treating diseases caused by parasitic worms.

Finding paves the way to possible treatments to infectious diseases and allergies

Parasites use a Trojan horse subterfuge to suppress the immunity of their victims when causing inception, according to to a study by the University of Edinburgh.

The finding could lead to possible treatments for infectious diseases and allergies.

Scientists say that parasites are able to secrete tiny sealed packages of genetic material into the cells of their victims, in order to suppress the immune response to infection.

The packages, known as vesicles, mimic those that are produced naturally in most organisms to carry out everyday functions such as transporting nutrients and chemical messages to and from cells. The parasite uses vesicles to hide its material inside a seemingly friendly exterior, like a Trojan horse.

The study, published in Nature Communications, was carried out on a parasite found in mice and revealed that the material in the packages is able to interact with the mouse's own genes. It manipulates the cell's machinery to suppress products linked to immunity, and therefore reduces resistance to infection.

The researchers say that the research could lead to new strategies for treating diseases caused by parasitic worms. It may also offer a possible way to treat allergies, such as hayfever, because the immune mechanism that parasites block is also linked to allergic reactions.

The genetic material from the parasites can also be detected in human blood, suggesting that this could be used as a test to detect infection in people.

Dr Amy Buck, who led the study, said: "We can see for the first time that parasites can use packages to sneak their material into the cells of other organisms. We now can develop ways to target this with implications for the billions of people and animals as risk of infectious diseases and allergy."

Image (C) David Williams

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.